Duvyzat

Active Ingredient(s): Givinostat Hydrochloride
FDA Approved: * March 21, 2024
Pharm Company: * ITALFARMACO SPA
Category: Genetic Disorders
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Duvyzat 8.86 mg/ml Oral Suspension
NDC: 11797-110
Labeler:
Italfarmaco Spa